Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al

Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al

Antonio Ieni,1 Valeria Barresi,1 Giuseppina Rosaria Rita Ricciardi,2 Barbara Adamo,3 Vincenzo Adamo,2 Giovanni Tuccari11Department of Human Pathology of Adult and Evolutive Age “Gaetano Barresi”, Section of Pathology, University of Messina, AOU “Policlinico G Martino&am...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ieni A, Barresi V, Ricciardi GRR, Adamo B, Adamo V, Tuccari G
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
triple-negative breast cancer
molecular subtype
targeted therapy
androgen receptor
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/24c93d61b5f947e195d2a24577096ac4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:24c93d61b5f947e195d2a24577096ac4
record_format dspace
spelling oai:doaj.org-article:24c93d61b5f947e195d2a24577096ac42021-12-02T00:17:25ZPrognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al1179-1314https://doaj.org/article/24c93d61b5f947e195d2a24577096ac42016-08-01T00:00:00Zhttps://www.dovepress.com/prognostic-value-of-androgen-receptor-expression-in-triple-negative-br-peer-reviewed-article-BCTThttps://doaj.org/toc/1179-1314Antonio Ieni,1 Valeria Barresi,1 Giuseppina Rosaria Rita Ricciardi,2 Barbara Adamo,3 Vincenzo Adamo,2 Giovanni Tuccari11Department of Human Pathology of Adult and Evolutive Age “Gaetano Barresi”, Section of Pathology, University of Messina, AOU “Policlinico G Martino”; 2Medical Oncology Unit AOOR Papardo-Piemonte, Department of Human Pathology of Adult And Evolutive Age “Gaetano Barresi”, University of Messina, Messina, Italy; 3Medical Oncology Hospital Clinic, Barcelona, SpainRecently, we read with great interest the review by Collignon et al entitled “Triplenegative breast cancer: treatment challenges and solutions”,1 which appeared in the last issue of Breast Cancer: Targets and Therapy. In this article, the authors extensively reviewed studies concerning the opportunity to identify triple negative breast carcinoma (TNBC) subtypes by newly proposed markers, taking into account their biological heterogeneity on the light of clinical implications.View original paper by Collignon et al.Ieni ABarresi VRicciardi GRRAdamo BAdamo VTuccari GDove Medical Pressarticletriple-negative breast cancermolecular subtypetargeted therapyandrogen receptorNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBreast Cancer: Targets and Therapy, Vol Volume 8, Pp 157-159 (2016)
institution DOAJ
collection DOAJ
language EN
topic triple-negative breast cancer
molecular subtype
targeted therapy
androgen receptor
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle triple-negative breast cancer
molecular subtype
targeted therapy
androgen receptor
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Ieni A
Barresi V
Ricciardi GRR
Adamo B
Adamo V
Tuccari G
Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al
description Antonio Ieni,1 Valeria Barresi,1 Giuseppina Rosaria Rita Ricciardi,2 Barbara Adamo,3 Vincenzo Adamo,2 Giovanni Tuccari11Department of Human Pathology of Adult and Evolutive Age “Gaetano Barresi”, Section of Pathology, University of Messina, AOU “Policlinico G Martino”; 2Medical Oncology Unit AOOR Papardo-Piemonte, Department of Human Pathology of Adult And Evolutive Age “Gaetano Barresi”, University of Messina, Messina, Italy; 3Medical Oncology Hospital Clinic, Barcelona, SpainRecently, we read with great interest the review by Collignon et al entitled “Triplenegative breast cancer: treatment challenges and solutions”,1 which appeared in the last issue of Breast Cancer: Targets and Therapy. In this article, the authors extensively reviewed studies concerning the opportunity to identify triple negative breast carcinoma (TNBC) subtypes by newly proposed markers, taking into account their biological heterogeneity on the light of clinical implications.View original paper by Collignon et al.
format article
author Ieni A
Barresi V
Ricciardi GRR
Adamo B
Adamo V
Tuccari G
author_facet Ieni A
Barresi V
Ricciardi GRR
Adamo B
Adamo V
Tuccari G
author_sort Ieni A
title Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al
title_short Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al
title_full Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al
title_fullStr Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al
title_full_unstemmed Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al
title_sort prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “triple-negative breast cancer: treatment challenges and solutions” by collignon et al
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/24c93d61b5f947e195d2a24577096ac4
work_keys_str_mv AT ienia prognosticvalueofandrogenreceptorexpressionintriplenegativebreastcarcinomaspersonalexperienceandcommentsonareviewaboutldquotriplenegativebreastcancertreatmentchallengesandsolutionsrdquobycollignonetal
AT barresiv prognosticvalueofandrogenreceptorexpressionintriplenegativebreastcarcinomaspersonalexperienceandcommentsonareviewaboutldquotriplenegativebreastcancertreatmentchallengesandsolutionsrdquobycollignonetal
AT ricciardigrr prognosticvalueofandrogenreceptorexpressionintriplenegativebreastcarcinomaspersonalexperienceandcommentsonareviewaboutldquotriplenegativebreastcancertreatmentchallengesandsolutionsrdquobycollignonetal
AT adamob prognosticvalueofandrogenreceptorexpressionintriplenegativebreastcarcinomaspersonalexperienceandcommentsonareviewaboutldquotriplenegativebreastcancertreatmentchallengesandsolutionsrdquobycollignonetal
AT adamov prognosticvalueofandrogenreceptorexpressionintriplenegativebreastcarcinomaspersonalexperienceandcommentsonareviewaboutldquotriplenegativebreastcancertreatmentchallengesandsolutionsrdquobycollignonetal
AT tuccarig prognosticvalueofandrogenreceptorexpressionintriplenegativebreastcarcinomaspersonalexperienceandcommentsonareviewaboutldquotriplenegativebreastcancertreatmentchallengesandsolutionsrdquobycollignonetal
_version_ 1718403789117980672

Ejemplares similares